Main Article Content


There are 8.4 million diabetes adult patients in Indonesia and most remained undiagnosed. Screening process for diabetes is very important. PERKENI has recommended the use of questionnaire and Oral Glucose Tolerance Test (OGTT) as risk factor screening tools. This study aimed to find out the use of PERKENI questionnaire and OGTT in adults as diabetes risk factor screening tools. This was a descriptive cross sectional study conducted in 2015 in Socah County Bangkalan. Participants (n=91) were interviewed regarding diabetes risk factor using PERKENI questionnaire. Anthropometric (height, weight, and abdominal circumference) measurements were also taken. The results were categorized into: very low risk, increased risk, moderate risk and high risk. Only those categorized as high risk were asked to take OGTT. Exclusion criteria were participants who had been diagnosed with diabetes by a physician and/or routinely taking anti diabetic medication, consumed drugs during the previous two weeks and does not finish the required procedures. From 91 eligible participants, only 9 (9.89%) were categorized as high risk. The result of OGTT were: 4 were within normal limit, 1 had impaired glucose tolerance (IGT) and 4 were newly diagnosed with diabetes. The use of PERKENI questionnaire and OGTT in high risk adult population as a diabetes risk factor screening tool increased new findings of diabetes cases. Our analysis may support the adoption of diabetes risk factor screening methods through questionnaires and OGTT in high risk adult population, especially in low resource setting.


Diabetes adults risk factor screening PERKENI questionnaire Oral Glucose Tolerance Test

Article Details

How to Cite
Kamal, R. H., Novendrianto, D., Chadijah, F., Prasetya, G. B., Pratama, G. S., Ariadnya, M. O., Larasati, N. G., Darain, N. L. F., Nanda, O., Mavita, S., Usamah, U., & Prajitno, J. H. (2017). DIABETES RISK FACTOR SCREENING IN ADULTS USING PERKENI QUESTIONNAIRE AND ORAL GLUCOSE TOLERANCE TEST IN SOCAH COUNTY, BANGKALAN. Folia Medica Indonesiana, 53(3), 199–203.


  1. Alberti KGMM, Zimmet P, Shaw J (2007). International diabetes federation: a consensus on type 2 diabetes prevention. Diabetic Medicine 24, 451-463
  2. Badan Penelitian dan Pengembangan Kesehatan (2013). Riset Kesehatan Dasar (RISKESDAS), Kementerian Kesehatan RI, Jakarta
  3. Christophi CA, Resnick HE, Ratner RE, et al (2013), confirming glycemic status in the diabetes prevention program: implication for diagnosing diabetes in high risk adults. J Diabetes Complications 27, 150-7
  4. Engelgau MM, Narayan KMV, Herman W (2000). Screening for type 2 diabetes. Diabetes Care 21, 1563-1580
  5. Fujimoto WY, Jablonski KA, Bray GA, et al (2007). Body size and shape changes and the risk of diabetes in the diabetes prevention program. Diabetes 56, 1680-5
  6. Herman WH, Edelstein SL, Ratner RE, et al (2013). Effectiveness and cost-effectiveness of diabetes prevention among adherent participants. Am J Manag Care 19, 194-202
  7. Herman WH, Smith PJ, Thompson TJ, Engelgau MM, Aubert RE (1995). A new and simple questionnaire to identify people at increased risk for undiagnosed diabetes. Diabetes Care 18, 382-7
  8. Hoerger TJ, Hicks KA, Sorensen SW, et al (2007), Cost-effectiveness of screening for pre-diabetes among overweight and obese U.S. adults. Diabetes Care 30, 2874-9
  9. InfoDATIN (2014), Situasi dan analisis diabetes. Kementerian Kesehatan RI, Jakarta Selatan
  10. International Diabetes Federation (2015). Diabetes Facts and Figures. Available from http://www. WDD15-guide/facts-and-figures.html. Accessed No-vember 19, 2015
  11. Ndraha S (2014). Diabetes mellitus tipe 2 dan tata-laksana terkini. Departemen Penyakit Dalam Fakultas Kedokteran Universitas Krida Wacana, Jakarta
  12. PERKENI (2011). Konsensus pengelolan dan pencegah-an diabetes melitus tipe 2 di Indonesia, PB PERKENI, Jakarta
  13. Perreault L, Ma Y, Dagogo-Jack S, et al (2008). Sex differences in diabetes risk and the effect of intensive lifestyle modification in the diabetes prevention program. Diabetes Care 31, 1416-21
  14. The Diabetes Prevention Program Research Group (2012). The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention. Diabetes Care 35, 723-30
  15. Valliyot B, Jayadevan S, Jayakumary M, Sudha BV (2013). Risk factors of type 2 diabetes mellitus in the rural population of North Kerala, India: a case control study. Diabetologia Croatia 42, 33-40
  16. Waugh N, Scotland G, McNamee P, et al (2007). Screening for type 2 diabetes: literature review and economic modelling. Health Technology Assessment 11
  17. Wild S, Gojka R, Anders G, Richard S, Hilary K (2004). Global prevalence of diabetes: estimates for the year 2000 and projections for 2030’, Diabetes Care 27, 1047-53
  18. World Health Organization (2015). Diabetes mellitus fact sheet. Available from Accessed November 23, 2015
  19. Wulandari MY, Isfandiari MA (2013). Kaitan sindroma metabolik dan gaya hidup dengan gejala komplikasi mikrovaskuler. Jurnal Berkala Epidemiologi 1, 224-23.